Niyojan

Mutual fund portfolio intelligence

Know exactly what
your money is doing.

Niyojan analyses your mutual fund portfolio at the stock level — showing you real overlap, hidden concentration risks, and data-backed recommendations. No trades, no commissions. Just clarity.

Currently in early access for Indian mutual fund investors.

ReplaceUnderperformer
Axis Bluechip Fund
1Y return at P23 — worse than 77% of Large Cap peers
1Y Return8.2%
Category Avg14.6%
PercentileP23
Alternatives
ICICI Pru BluechipP82
Mirae Large CapP76
WatchCyclical Dip
Kotak Emerging Equity
1Y dipped to P41, but 3Y at P71 and 5Y at P68. Monitor, don't exit.
1Y PercentileP41
3Y PercentileP71
5Y PercentileP68
Strong long-term track record. Keep watching.
OverlapConsolidate
SBI Bluechip ∩ HDFC Top 100
41.3% of the same stocks. Two expense ratios for identical exposure.
41.3%
Top sharedRIL, HDFC Bank
TER saving₹847/yr
Keep the better performer, exit the other.
Lower CostTER
HDFC Mid-Cap Opportunities
TER of 1.62% is much higher than category average of 0.89%.
Current TER1.62%
Category Avg0.89%
Extra cost₹2,190/yr
Cheaper option
Motilal Midcap0.57% · P74
DiversifyAMC Risk
HDFC Mutual Fund
54% of portfolio in one fund house. Regulatory risk if AMC faces issues.
HDFC weight54%
Ideal max30%
HDFC funds4 of 9
Move 1–2 funds to other AMCs with similar performance.
MismatchRisk Profile
Quant Small Cap Fund
Your profile is Moderate, but this fund has very high volatility.
Your profileModerate
Fund riskVery High
Allocation18%
Consider instead
Kotak Flexi CapModerate · P69
ExploreAdd Fund
Add a Debt Fund
100% equity portfolio. Debt would reduce volatility for your Moderate profile.
Current equity100%
Suggested debt15–25%
Health impact+6 pts
Top debt picks
HDFC Short Term7.1% · 0.36%
ICICI Corp Bond7.4% · 0.40%

The problem

Most investors don't know what's inside their portfolio.

Blind overlap

You hold 5 funds thinking you're diversified, but 3 of them own the same top stocks. You're paying 3 expense ratios for the same exposure.

No real benchmarking

Is your fund actually good, or just riding a bull market? Without percentile rankings against category peers, you can't tell.

Hidden concentration

54% of your portfolio in one fund house? If that AMC faces regulatory issues, your entire portfolio is exposed. Most apps don't flag this.

Cost opacity

Expense ratios are buried in fine print. You don't know how much you're actually paying in fees — or whether a cheaper alternative exists.

What Niyojan does

Real analysis. Real data. No fluff.

How it works

Three steps to portfolio clarity.

1

Import your portfolio

Request your CAS from CAMS or KFintech, or enter your holdings manually. We parse every transaction, folio, and NAV automatically.

2

Get your analysis

Within seconds, see your portfolio health score, stock-level overlap, concentration risks, expense ratio breakdown, and fund-by-fund percentile rankings.

3

Act on recommendations

Receive specific, data-backed suggestions — which fund to watch, which to replace, where to diversify. Each recommendation explains why, with real numbers.

Our philosophy

Built on honesty, not hype.

We don't sell funds

Niyojan doesn't execute trades or earn commissions. We have zero incentive to push you toward any particular fund. Our only job is to give you the clearest picture of your portfolio.

We don't fake data

Every number you see — percentile ranks, overlap percentages, health scores — comes from real calculations on real fund data. We source NAVs from AMFI, holdings from fund house disclosures, and expense ratios from regulatory filings.

We don't oversimplify

A fund having a bad year doesn't mean it's a bad fund. If its 3-year and 5-year track record is strong, we'll tell you to watch it, not panic-sell. Context matters, and our recommendations reflect that.

We're early and honest about it

Niyojan is a new product. We're not going to claim millions of users or industry awards we don't have. We're building something genuinely useful, one feature at a time, and we'd rather earn your trust than manufacture it.

Data integrity

Where our data comes from.

NAV data
AMFI (Association of Mutual Funds in India) — daily updates
Fund holdings
Monthly disclosures from fund houses (HDFC, ICICI, SBI, Kotak, Nippon, Mirae, Axis, UTI, Quant, and more)
Expense ratios
AMFI regulatory filings — synced regularly
Market cap data
AMFI market capitalisation classifications — refreshed periodically
Percentile rankings
Computed in-house from NAV history — 1Y, 3Y, 5Y CAGR vs category peers

Questions

Frequently asked.

Is Niyojan a trading platform?

No. Niyojan is an analysis and intelligence tool. We don't execute trades, manage money, or provide personalized investment advice. We help you understand what you already own.

How do you make money?

We're currently in early access and focused on building the best product. We don't earn commissions on fund sales. Our future business model will be transparent and aligned with your interests — not fund distributors'.

Is my portfolio data safe?

Your data is encrypted in transit and at rest. We don't share your portfolio data with third parties. We don't sell data. Your CAS is processed to deliver the app's features to you — nothing else.

How accurate is the overlap analysis?

We use actual stock-level holdings from monthly fund disclosures. This is the same data fund houses report to SEBI. It's as accurate as the source — typically updated monthly.

What does the health score measure?

It's a composite score (0–100) across five dimensions: diversification quality, overlap pressure, concentration risk, cost efficiency, and fund quality. Each dimension is scored independently so you can see exactly where your portfolio is strong or weak.

Can I use Niyojan for free?

Yes. Niyojan is free during early access. We'll communicate any changes well in advance.